The U.S. Congress quietly empowered the Food and Drug Administration (FDA) by approving a provision in the omnibus spending bill that would give the agency the ability to ban off-label uses of medical devices. Doctors are concerned that the new bill would allow the FDA – which is led by non-pract
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…